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ABSTRACT 
 
Huntington’s Disease (HD) is a dominantly inherited neurodegenerative disease caused by alterations in the 
huntingtin gene (htt). Transcriptional dysregulation is an early event in HD progression. Protein acetylation and 
methylation particularly on histones regulates chromatin structure thereby preventing or facilitating transcription. 
Although protein acetylation has been found to affect HD symptoms, little is known about the potential role of 
protein methylation in HD pathology. In recent years, a series of proteins have been described that are responsible 
for methylating and demethylating histones as well as other proteins. We carried out systematic genetic interaction 
studies testing lysine and arginine methylases and demethylases in a Drosophila melanogaster HD model. We found 
that modulating methylation enzymes that typically affect histone positions H3K4, H3K36 or H3K79 had varying 
effects on HD pathology while modulating ones that typically affect constitutive heterochromatin marks at H3K9 
and H4K20 generally had limited impact on HD pathology. In contrast, modulating enzymes acting on the 
facultative heterochromatin mark at H3K27 had specific effects on HD pathology, with reduction of the demethylase 
Utx rescuing HTT induced pathology while reducing PRC2 complex core methylase components led to more 
aggressive pathology. Further exploration of the mechanism underlying the methylation-specific interactions suggest 
that these lysine and arginine methylases and demethylases are likely exerting their influence through non-histone 
targets. These results highlight a novel therapeutic approach for HD in the form of Utx inhibition. 
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INTRODUCTION 
 
Huntington’s disease (HD) is a fatal, neurodegenerative disorder caused by a CAG repeat expansion in the 
Huntingtin (HTT) gene, which encodes an abnormally long polyglutamine (polyQ) repeat in the HTT protein (1). In 
spite of its monogenic nature, the pathogenesis of HD is complex. Prior studies have identified over 700 proteins 
interacting with mutant HTT, which are involved in transcription, DNA maintenance, cell cycle regulation, cellular 
organization, protein transport, energy metabolism, cell signaling, and protein homeostasis (2).  
 
Multiple studies have noted that altered modification of lysine residues is associated with HD (3-5). This coupled 
with observed transcription changes in HD has led to the idea that dysregulated lysine modifications might affect 
pathogenesis by altering histone modifications and thus transcription. Acetylation of histones is a well-known event 
that affects gene expression by relaxing chromatin structure.  Protein methylation occurs on lysine and arginine 
residues and in many cases affects the same lysine residues as acetylation suggesting a potential interplay between 
their effects on cellular and pathogenic processes. Consistent with this, several studies have identified altered 
methylation patterns in HD patients and models (6-8). 
 
However, histones are only one of many substrates targeted by lysine modifying enzymes. Both acetylation and 
methylation affect a wide-array of proteins (for reviews see (9, 10) ) including histones and non-histone proteins 
with a wide-variety of functions, including transcriptional regulators, signaling molecules, metabolic enzymes and 
components of the cytoskeleton. Furthermore, the sets of enzymes participating in the modifications of histones and 
other proteins are not exclusive but overlapping. For example, the tumor suppressor p53 can be acetylated or 
methylated at several lysine or arginine residues, to influence its stability and activity (11-13). The lysine 
methyltransferases Set9 (12) and Set8/PR-Set7 (14) that act on p53 also modify histone H3 at lysine K4 (15) and 
histone H4 at lysine K20 (16), respectively. Thus, specific modifying enzymes can affect transcription by modifying 
both histone and non-histone proteins. 
 
Despite the high number of non-histone acetylation and methylation targets, the majority of studies investigating the 
role of post-translational modifications (PTMs) on the pathogenesis of Huntington's disease have focused on the 
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regulation of gene expression by altered modifications of histones. Transcriptional control relies on chromatin 
structure, which is regulated in part by PTMs of unstructured N-terminal regions of histones that directly change the 
intrinsic biophysical properties of local chromatin or indirectly allow or prevent docking of effector molecules (17-
19). Histone methylation status determines the chromatin environment and thereby regulates transcription (20). 
Histone methylation marks can be divided into two major categories: active or repressive chromatin marks (21, 22) 
(Table 1). Simplistically, methylated H3K4, H3K36 and H3K79 are associated with actively transcribed genes (23, 
24), whereas methylated H3K9, H4K20 and H3K27 are usually associated with inactive regions (25). Drosophila 
melanogaster has single orthologs for most of human histone methylase and demethylase genes and can be an ideal 
in vivo system to test the role of various histone methylation modifying enzymes on Huntingtin pathology.  
 
In this study, we have sought to identify which methylation modifying loci affect HD pathology by systematically 
evaluating the effect of identified methyltransferases and demethylases in a Drosophila model of HD.  In addition, 
we have sought to test the assumption of whether the key loci exert their effects by modifying histone residues or 
whether they exert their effect through other targets of methylation. 
 
RESULTS 
 
Modulating active chromatin histone methylation marks has varying effects on HD pathology  
We first investigated methyltransferase and demethylase enzymes that act on lysine residues of histone tails whose 
methylation is associated with active transcription: H3K4, H3K36 or H3K79. H3K4 methylation represents a 
specific mark for epigenetic transcriptional activation and tri- and di- methylation on histone H3 at Lys 4 
(H3K4me3/me2) is often found at active genes. H3K4me3 is highly enriched around transcriptional start sites (TSS) 
(26), while H3K4me2 is present both at TSS and coding regions of transcribed genes (26-31). Di- and tri-methylated 
forms of H3K36 residue are enriched at coding regions of actively transcribed genes and are involved in regulating 
transcriptional elongation (26, 32).  H3K79 monomethylation is also enriched in the coding region of active genes, 
while the dimethylated form can be found on both the TSS and gene body of active genes (26).  
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In Drosophila, three non-redundant proteins - SET domain containing 1 (Set1), Trithorax (Trx) and Trithorax-related 
(Trr) - are found in complexes similar to the yeast COMPASS methyltransferase complex that are capable of 
methylating the H3K4 residues (33). Among these, Set1 was shown to act as the main global H3K4 di- and 
trimethylase throughout Drosophila development (34).  
 
To determine whether H3K4 specific methyltransferases affect HD pathology, we conducted genetic interaction 
crosses to test the effects of reduced levels of methyltransferases (either by heterozygous loss of function mutations 
or by RNAi depletion) on HD phenotypes induced by the neuronal expression of human Httex1p-Q93 transgenes. 
When expressing mutant Httex1p-Q93 in all neurons with the pan-neuronal elav-GAL4 driver, adult flies exhibit 
reduced eclosion rates and neuronal degeneration as observed by decreased number of rhabdomeres in ommatidia in 
the pseudopupil assay (35). RNAi knockdown of Set1 (GD12893) (33) in Httex1p-Q93 expressing flies did not 
influence viability (1.06 relative eclosion compared to control flies, not significant (N.S.), Fig. 1A) or cause a 
significant change in the number of rhabdomeres per ommatidium (+0.02 rhabdomeres per ommatidium in Htt Set1-
RNAi/+ vs. Htt +/+ control, N.S., Fig. 1B), indicating that reducing Set1 has no impact on HD pathology.  
 
In contrast, reducing Trx using the hypomorphic trx
1
 allele (36), resulted in significant amelioration of HD 
pathology in Httex1p-Q93 expressing flies heterozygous for trx
1
. This was apparent both by a positive change in the 
number of rhabdomeres per ommatidium (+0.36 in Htt trx
1
/+ vs. Htt +/+, P=0.02, Fig. 1B) and significantly 
improved viability (relative eclosion of 1.75, P=0.003, Fig. 1A), indicating that Trx inhibition has a positive impact 
on HD pathology. 
 
Reducing the levels of Trr by heterozygosity of the trr
1
 null allele (37) also rescued the pseudopupil phenotype 
significantly (+0.91 rhabdomeres per ommatidium in Htt trr
1
/+ vs. Htt +/+ control, P=4x10
-5
, Fig. 1B), but resulted 
in reduced viability (0.64 relative eclosion compared to control, P=0.004, Fig. 1A). Similar results were also 
obtained by reduction of Trr in HD flies by heterozygous trr
3
 which removes the SET domain (38) (Fig. S1 A and 
B). We conclude that unlike the globally acting Set1, reducing the levels of the more specialized H3K4 methylases, 
Trx and Trr, has a positive impact on Htt induced neurodegeneration. 
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Several enzymes are involved in the removal of methyl marks from H3K4 in Drosophila. Among them, Su(var)3-
3/dLsd1 (Drosophila ortholog of lysine-specific demethylase 1) specifically demethylates H3K4me2 and H3K4me1 
residues (39, 40) while Lid (little imaginal discs), the ortholog of the Jarid1 family of JmjC domain-containing 
proteins, demethylates H3K4me3 (41-43). In addition to Su(var)3-3 and Lid, Drosophila Kdm2 (Lysine (K)-specific 
demethylase 2) has also been shown to possess H3K4me3-specific lysine demethylase activity in adult flies (44). 
We have previously reported that reducing Lid ameliorates HD pathology (7). Similarly, an RNAi (GD9296) line of 
Su(var)3-3 rescued the pseudopupil phenotype (+0.32 rhabdomeres per ommatidium in Htt Su(var)3-3-RNAi vs. Htt 
+/+, P=0.03, Fig. 1B) and viability (1.54 relative eclosion, P=0.0001, Fig. 1A). Heterozygous loss of Kdm2 by the 
amorphic Kdm2
DG12810
 allele (45) has also ameliorated neurodegeneration (+0.66 rhabdomeres per ommatidium in 
Htt Kdm2/+ vs. Htt +/+, P=0.01, Fig. 1B) and improved viability (1.94 relative eclosion, P=2x10-7, Fig. 1A).  Thus, 
reduction of H3K4 demethylases can have a positive impact on HD pathology.  
 
Next we investigated the effects of modulating H3K36 methylation status on HD pathology. In Drosophila, H3K36 
trimethylation is catalyzed by the product of the Set domain containing 2 gene (Set2, dHypb) and dimethylation is 
mediated by the product of the absent, small, or homeotic discs 1 gene (Ash1) (46) and Mesoderm-expressed 4 gene 
(Mes4) (47). We tested an RNAi line of Set2 (B24108) that was shown to eliminate H3K36 methylation in larvae 
(48). We saw significant rescue of HTT induced neurodegeneration when Set2 was downregulated (+0.51 
rhabdomeres per ommatidium in Htt Set2-RNAi/+ vs. Htt +/+, P=0.02, Fig. 1D) while no significant change in 
viability was observed (relative eclosion of 1.23, N.S., Fig. 1C). 
 
The methyltransferase activity of Ash1 was initially reported to be directed towards H3K4, H3K9 and H4K20 (49, 
50), however, recent evidence supports its dimethylation activity specifically towards H3K36 in vitro (46) and in 
vivo (51, 52). In contrast to the positive effect from reducing Set2, heterozygosity of ash1
22
, a null allele (53), 
resulted in an enhancement of HD pathology in Httex1p-Q93 expressing flies, apparent in both significantly more 
neurodegeneration (-0.75 rhabdomeres per ommatidium in Htt ash1
22 
/+ vs. Htt +/+, P=0.0002, Fig. 1D) and a 50% 
reduction in relative eclosion rate (0.51, P=0.0001, Fig. 1C).  
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Demethylation of histone H3K36me3/me2 (and H3K9me3/me2) is mediated by the KDM4 subfamily, which 
belongs to a large family of Jumonji C (JmjC) domain-containing proteins (22, 43, 54). In Drosophila, Kdm4A is 
capable of demethylating H3K36me2 and H3K36me3 and regulates H3K36 methylation at multiple euchromatic 
sites (43, 55). To test the influence of Kdm4A on HD pathology we used the Kdm4A
KG04636
 allele in which a P 
element inserted in the coding region of Kdm4A abrogates its expression (55). Reduced levels of Kdm4A (i.e. Htt-
expressing flies that are also heterozygous for Kdm4A
KG04636
) led to significantly increased viability (1.45 relative 
eclosion, P=0.004, Fig. 1C) but had no effect on neurodegeneration (+0.10 change of rhabdomeres per ommatidium, 
N.S., Fig. 1D). 
 
The grappa gene (gpp) is solely responsible for catalyzing the mono-, di-, and tri- methylation of H3K79 (56, 57) 
and has the unusual property of exhibiting phenotypes and genetic interactions that are characteristic of both 
Polycomb-group (PC-G) and Trithorax-group (TRX-G) genes (56). We tested two X-ray induced loss of function 
alleles of gpp, gpp
X
 and gpp
XXV
. Heterozygous reduction of Gpp in Htt-expressing flies resulted in modest, yet 
significant increase in neurodegeneration (-0.23 rhabdomeres per ommatidium in Htt gpp
X
/+ vs. Htt +/+ control, 
P=0.01, Fig. 1F) with no significant impact on viability (relative eclosion of 1.31, N.S., Fig. 1E). Reducing Gpp by 
the other loss of function allele, gpp
XXV
, gave similar results with even stronger neurodegeneration (Fig. S1 A and B). 
 
Modulating histone marks specific for constitutive heterochromatin marks has limited impact on Htt 
pathology 
Next we investigated the effects of enzymes modulating epigenetic marks specific for constitutive heterochromatin, 
H3K9 and H4K20 methylation, on HD pathogenesis.  
 
H3K9 trimethylation represents a specific mark for epigenetic repression that recruits the Su(var)205/HP1 protein to 
methylated histones, which then induces heterochromatin formation (58-60). Three SET domain containing lysine 
methyltransferases are responsible for methylating the H3K9 residue in fruit flies: Eggless (Egg), the Drosophila 
ortholog of human SETDB1 and mouse ESET (61-63); Su(var)3-9, the Drosophila ortholog of human Su(var)3-9 
(64); and G9a, the Drosophila ortholog of human and mouse G9a (65, 66). These enzymes have different expression 
patterns, preferred methylation substrates and functions (67).  
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Mutants or transgenic insertion lines of each of the three genes were tested for effects on HTT-mediated 
degeneration. Heterozygous reduction using a loss of function allele of eggless, egg
1473
 (68) did not have any 
significant effect on either viability (1.29 relative elosion, N.S. Fig. 2A) or neurodegeneration (-0.1 change of 
rhabdomeres per ommatidium, N.S., Fig. 2B). Testing with an independent loss of function allele egg
235 
(68) gave 
similar results (Fig. S2 A and B).  
 
Heterozygous reduction of Su(var)3-9 with an amorphic allele Su(var)3-9
1
 (69) resulted in no effect on 
neurodegeneration (+0.21 change of rhabdomeres per ommatidium, N.S., Fig. 2B) albeit reduced viability (relative 
eclosion of 0.69, P=0.02, Fig. 2A) in Htt-challenged flies. Testing with an independent amorphic allele, Su(var)3-9
2
 
(70), gave similar result on neurodegeneration but ameliorated viability (Fig. S2 A and B). 
 
An RNAi line for G9a, GD9876, was confirmed by Q-RT-PCR to reduce G9a mRNA levels to 63% of control (Fig. 
S2 C). Htt G9a-RNAi/+ flies showed similar viability relative to control Htt +/+ (0.96 relative eclosion, N.S., Fig. 
2A) and a non-significant change of rhabdomeres per ommatidium (+0.17, N.S., Fig. 2B). Heterozygous reduction 
using allele G9a
MB11975
, in which a Gal4 enhancer trap element is inserted into the 2nd exon of the gene, also did not 
significantly alter neurodegeneration but did reduce viability (Fig. S2 A and B).  
 
The effect on HD pathology of reducing the activity of the H3K9 demethylases that exert the opposing activity was 
examined. JmjC-domain containing histone demethylase 2 (JHDM2), was shown previously to specifically 
demethylate H3K9 (71). Heterozygous reduction of JHDM2 (JHDM2
KG06444
/+) did not affect neurodegeneration 
significantly (-0.25 change of rhabdomeres per ommatidium in Htt JHDM2/+ vs. Htt +/+, N.S., Fig. 2B) but 
improved viability (relative eclosion of 1.60, P=4x10
-5
, Fig. 2A) compared to the controls.  
 
The demethylase encoded by the Lysine (K)-specific demethylase 4B (Kdm4B) gene was shown to act on both H3K9 
and H3K36 residues (72). Using heterozygous Kdm4B
03531
, a P element insertion allele that results in substantial 
reduction in Kdm4B protein levels in heterozygotes (73), we did not observe a significant impact on either viability 
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(relative eclosion rate of 1.10, N.S., Fig. 2A) or neurodegeneration (0.13 change of rhabdomeres per ommatidium, 
N.S., Fig. 2B) .  
 
Similar to H3K9 methylation, H4K20 mono- or tri-methylation represents a specific mark for epigenetic 
transcriptional repression. H4K20 trimethylation is mainly enriched in pericentric heterochromatin regions where it 
plays a central role in the establishment of constitutive heterochromatin (74). PR/SET domain containing protein 7 
(PR-Set7) specifically acts to mono-methylate (75, 76) whereas histone methyltransferase 4-20 (Hmt4-20) is 
responsible for di- and tri-methylating H4K20 (77). We tested the effects of the hypomorphic PR-Set7
1
 allele (78) 
on Htt induced pathology and did not see any significant impact on either viability (relative eclosion of 0.80 in Htt 
PR-Set7
1
/+ vs. Htt +/+, N.S., Fig. 2C) or neurodegeneration (+0.05 change of rhabdomeres per ommatidium, N.S., 
Fig. 2D). Similarly, the Hmt4-20
KG01771 
allele, an allele with a P-element inserted in the 5’ UTR of the Hmt4-20-RA 
transcript, did not result in any significant difference in Htt Hmt4-20/+ flies compared to their control siblings (Htt 
+/+) in either viability (relative eclosion of 0.91, N.S., Fig. 2C) or change of rhabdomeres per ommatidium (-0.23, 
N.S., Fig. 2D).  
 
Based on the results described above involving mutant Huntingtin and H3K9 methyltransferases and demethylases 
and H4K20 methyltransferases, we conclude that modulating constitutive heterochromatin marks does not exert a 
significant impact on HTT mediated HD pathology in Drosophila. 
 
Altered levels of enzymes modulating the facultative heterochromatin mark H3K27me3 impacts HD 
pathology 
Tri-methylated lysine 27 on histone H3 (H3K27me3) is the most well-characterized mark for “facultative 
heterochromatin” and is critical for the repression of key transcriptional regulators during development (79). It was 
previously reported that full length Huntingtin acts as a facilitator of the multi-subunit histone H3 lysine 27 (H3K27) 
methyltransferase complex Polycomb Repressive Complex 2 (PRC2) in mice, and mouse embryos lacking 
Huntingtin display a series of phenotypes similar to that of PRC2-deficient embryos (80). We asked if modulation of 
enzymes acting on the H3K27me3 repressive mark influences expanded polyQ Huntingtin induced pathology. The 
Polycomb-group protein E(z) is the only protein found so far to be responsible for methylating H3K27 in 
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Drosophila (81-83). Also, while there are multiple H3K27me3-specific demethylases, including UTX, UTY, and 
JmjD3 in mammalian cells, Drosophila have a single histone demethylase, Utx, capable of specifically 
demethylating di- and tri-methylated H3K27 (84). The fact that there is only one enzyme catalyzing each direction 
of methylation/demethylation makes testing H3K27 specific enzymes straightforward in Drosophila. 
 
The null allele E(z)
731
 has a nonsense mutation within the SET domain, the catalytic part responsible for the 
methyltransferase activity, and produces no detectable protein (82). Compared to Htt expressing control flies, Htt-
expressing flies heterozygous for E(z)
731
/+ had significantly lower viability (relative eclosion of 0.54, P=3.0x10
-7
, 
Fig. 3A) as well as significantly fewer rhabdomeres per ommatidium (-0.34 less rhabdomeres per ommatidium 
compared to the control, P=0.02, Fig. 3B). Significant reduction in viability (79% relative eclosion rate, P=0.004) 
and neurodegeneration (-0.48 less rhabdomeres per ommatidium compared to control, P= 0.008) was also observed 
with another null allele, E(z)
63
 (Fig. S3 A and B). These results indicate that reducing the E(z) methylase enhances 
HD pathology. 
 
However, E(z) does not function as a single enzyme but as the catalytic subunit of the PRC2 protein complex (81), 
which besides E(z), contains three core subunits: Extra sex combs (Esc, human EED ortholog in Drosophila), 
Suppressor of zeste-12 (Su(z)12), and nucleosome-remodeling factor 55 (NURF-55) (81, 82). Esc is a WD repeat 
containing protein which binds specifically to trimethylated H3K27 whereas Su(z)12 is proposed to bind E(z) and 
promote PRC complex assembly (85). Both Esc and Su(z)12 are required for the integrity of PRC2 and PRC-
mediated H3K27 methylation (86, 87). To investigate possible interactions of Htt with these components of the 
PRC2 complex, we carried out genetic interaction tests with mutant alleles of Esc and Su(z)12 as well as non-core 
components of PRC2. Similar to E(z), heterozygous reduction of Esc by the esc
5
 null allele enhanced pathology. We 
observed severely reduced viability (relative eclosion of 0.16, P=1.50x10
-12
, Fig. 3A) and significantly enhanced 
neurodegeneration (-0.52 less rhabdomeres per ommatidium in Htt esc
5
/+ vs. Htt +/+ flies, P=0.02, Fig. 3B). 
Heterozygous reduction of Su(z)12 by the loss of function allele Su(z)12
3
 also resulted in significantly enhanced 
neurodegeneration (-0.69 less rhabdomeres in Htt Su(z)12
3
/+ than in Htt +/+, P=0.0007, Fig. 3B) albeit positive 
impact on viability (1.30 relative eclosion, P=0.03, Fig. 3A). In contrast, when we tested two non-core components 
of PRC2, Pcl and Jing, we did not observe any significant impact on HD pathology (Fig. S3 A and B). However, 
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reduced levels of a third non-core PRC2 component, Jarid2, by heterozygous Jarid2
MB00996 
null allele suppressed HD 
pathology as evidenced by significantly higher average number of rhabdomeres per ommatidium (+0.54 more than 
in controls, P=0.008, Fig. S3 B) and increased viability (3.18 relative eclosion rate, p=2.8x10
-15
, Fig. S3 A). As a 
comparison, we also tested Pc, a core component of PRC1, which also compacts chromatin but catalyzes H2A 
monoubiquitylation independently of PRC2 and H3K27me3 (88), and saw no significant effect on the survival of 
photoreceptor neurons (-0.23 less rhabdomeres per ommatidium in Htt Pc
1
/+ than Htt +/+, N.S., Fig. S3 B) albeit Htt 
Pc
1
/+ showed improved viability than in Htt +/+ control flies (relative eclosion of 1.99, P=0.003, Fig. S3 A).  
 
Based on the above, we reasoned that reducing the activity of demethylase Utx that exerts an opposite enzymatic 
function on H3K27me3 might rescue HD pathology. First we tested the Utx
1
 allele, which has a premature 
termination codon in the JmjC domain and is a strong hypomorph (89). Consistent with our predictions, 
heterozygous Utx
1
 rescued the HD neurodegeneration phenotype, with the number of rhabdomeres per ommatidium 
significantly higher in Htt Utx
1
/+ flies compared with Htt-expressing control flies (+0.44 more rhabdomeres per 
ommatidium, P=0.02, Fig. 3B) while it had no significant impact on viability (relative eclosion of 0.96, N.S., Fig. 
3A). Testing a second allele, Utx
2
, which contains a missense mutation in the C terminus resulting in a reduced 
amount of Utx protein (89), also gave similar results (Fig.  S3 A and B). Therefore, contrary to the effect of reducing 
E(z), heterozygous reduction of Utx ameliorates mutant Huntingtin induced neurodegeneration. Thus, manipulations 
that tend to increase H3K27 methylation (e.g. lower Utx) tend to rescue HTT induced pathology while those that 
tend to decrease H3K27 methylation (e.g. reducing PRC2 core complex components) lead to more aggressive 
pathology.    
 
Recently, a small molecule, GSK-J1, was developed to be a selective catalytic site inhibitor of H3K27me3-specific 
jumonji JMJ subfamily of proteins (90). Drosophila H3K27me3-specific demethylase Utx contains all the critical 
amino acids involved in GSK-J1 binding (data not shown). Since reducing Utx activity genetically rescued HD 
pathology, we explored the possibility of rescuing the HD pathology pharmacologically with this Utx inhibitor. We 
compared the effect of increasing concentrations of the H3K27me3-specific inhibitor, the cell-penetrating ester 
prodrug GSK-J4, butyrate (BA, positive control) and DMSO (negative control). As a histone deacetylase inhibitor 
shown in previous studies (35), BA is neuroprotective as Htt-expressing flies raised on 100 mM BA had 
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significantly higher average number of rhabdomeres per ommatidium than DMSO treatment (5.21 vs. 4.3, 
P=4.05x10
-9
, Fig. 3C). Interestingly, flies on the higher concentrations (10 µM and 100 µM) of GSK-J4 showed 
higher number of rhabdomeres per ommatidium, with the average of 4.9 for 100 µM and 4.65 for 10 µM, which are 
both significant higher compared to the 0.1% DMSO control (P=2.00x10
-5 
and P=0.05, respectively. Fig. 3C). The 
improvement by 10 µM GSK-J4 was not due to the reduction of the level of soluble Huntingtin (Fig. S4). In 
contrast, flies on the lower concentrations (100 nM and 1 µM) of GSK-J4 showed no difference relative to the 
DMSO control (Fig. 3C). We also tested transferring the Htt-expressing flies to the drug-containing food after their 
eclosion but saw no difference between GSK-J4 and DMSO treatment (data not shown). Thus both genetically and 
pharmacologically, manipulation of the methylation activity of Utx holds promise as a novel therapeutic drug target 
for ameliorating HD symptoms.  
 
Partial loss of Utx reduces Htt protein aggregation 
As genetic factors mediating H3K27 methylation or demethylation showed opposite effects on mutant HTT induced 
phenotypes suggesting a potentially attractive therapeutic target, we decided to further investigate the potential 
involvement of Utx in HD pathology. First, we needed to exclude the possibility that reduced Utx ameliorates HD 
phenotypes in the model because Htt transgene expression per se is affected by Utx mutations. We performed q-RT-
PCR analysis on Htt-challenged Utx mutant (elav-GAL4/w; Utx
1
/+; UAS-Httex1p-Q93/+) or Htt-challenged control 
siblings (elav-GAL4/w; +/+; UAS-Httex1p-Q93/+) and found no significant difference in the level of Htt 
expression in Utx
1
 heterozygotes (Fig. 4A). Similar results were also obtained with Utx
2
 heterozygotes (Fig. S3 C). 
This indicates that the rescuing effect of Utx reduction on HD pathology is not due to a reduced level of Htt 
transgene expression.  
 
As aggregation of mutant Htt is a hallmark feature of HD, we investigated whether reducing Utx affects HTT 
protein accumulation and aggregation. To test this, we drove the expression of mutant Huntingtin exon1 in neurons 
with elav-GAL4 in the presence or absence of Utx mutations and examined Htt protein accumulation and 
aggregation in larval eye discs. When the tissues were immuno-stained with Htt exon1-specific antibody (VB3130), 
we observed stronger Htt protein aggregation with the expression of Httex1p-Q120 compared to Httex1p-Q93, 
therefore we used Httex1p-Q120 for further immunofluorescence image analysis (Fig. 4B). By counting Htt 
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aggregate-positive puncta on compiled 3D images, we found that eye discs of Htt expressing flies heterozygous for 
Utx (elav-GAL4/+; Utx
1
/+; UAS-Httex1p-Q120/+) had significantly less HTT puncta than eye discs of control 
siblings (elav-GAL4/+; +/+; Httex1p-120Q/+) (Figure 4C). This result indicates that heterozygous reduction of Utx 
decreased the level of HTT protein aggregation. 
 
Interrogation of H3K27 methylation levels detect no change in HD flies 
Our genetic interaction tests suggested that expression of mutant Htt might lead to decreased H3K27 methylation 
and reduction of Utx activity might have rescued neurodegeneration by correcting the histone methylation 
imbalance. To test this possibility, we first investigated whether global H3K27 trimethylation was affected by Htt 
expression. We quantified the level of H3K27me3 in the heads of flies expressing Httex1p-Q93 vs. Httex1p-Q20 
controls by the elav-GAL4 driver using quantitative western blot analysis (Fig. 4D and 4E). In contrast of the 
significantly diminished H3K27me3 levels in larval samples of E(z) null trans-heterozygotes E(z)
731
/E(z)
63
 (Lane 15 
in Fig. 4D) relative to E(z)
731
/+ heterozygotes (Lane 14 in Fig. 4D), we did not observe any significant decrease in 
H3K27 trimethylation level in fly head samples from either sex expressing Httex1p-Q93 (Lane 2~7) compared to 
Httex1p-Q20 controls (Lane 8~13 in Fig. 4D, quantification in Fig. 4E), suggesting a lack of effect from HTT 
challenge on global level of H3K27me3 in HD flies. 
 
Although we did not detect a global change in H3K27me3 levels in HTT expressing flies it is possible that HD 
challenge modifies the H3K27me3 marks on specific genes. We tested this by chromatin immunoprecipitation 
(ChIP). From the publically available modENCODE Drosophila adult head H3K27me3 ChIP-Chip or ChIP-seq 
datasets (91) (#372-male, ChIP-Chip; #346-female, ChIP-Chip; #820-male, ChIP-seq), we identified a common set 
of 708 genes which, with 1 kb flanking sequences, overlap H3K27me3 enriched chromatin regions. We queried 
these 708 putatively H3K27me3 regulated genes for expression in adult heads using the modENCODE high-
throughput RNA-seq data (92) and selected a set of 16 genes for ChIP-qPCR analysis, including genes that are not 
expressed (ato, eve, gsb-n, Ubx; Reads Per Kilobase of transcript per Million mapped reads (RPKM) = 0), or 
expressed in low (eyg, caup, E5, dve, mirr; RPKM < 10), moderate (Idgf3, hth, mAcR, srp, nAcR-beta21C; 
20 < RPKM < 50) or high levels (ninaC, Obp99c; RPKM > 200) in heads of 4 day old females. We prepared 
chromatin from heads of 3 day old Httex1p-Q93 (mutant) or Httex1p-Q20 (control) expressing flies and performed 
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ChIP-qPCR analysis with H3 and H3K27me3 specific antibodies (Fig. 5). The H3K27me3 signal was at least an 
order of magnitude higher at all of the selected loci than in a control genomic region, F22. Furthermore, we found a 
moderately negative correlation between gene expression (modENCODE RNA-seq) and H3K27me3 enrichment 
data in both flies expressing mutant (R=-0.58, P=0.019) or control (R=-0.47, P=0.067) HTT. Surprisingly, however, 
a statistically significant change in H3K27me3 levels between the mutant and control could not be detected (two-
way ANOVA). This, together with the immunoblot data suggest that H3K27me3 methylation balance is not 
disturbed in mutant HTT challenged flies, therefore the rescuing effect of Utx is likely not acting by restoration of 
wild-type H3K27 methylation patterns.  
 
Direct manipulation of H3K27 residue by PTM mimetics 
As the primary function of Utx is thought to be the demethylation of the H3K27 lysine residue, it was surprising that 
we could not detect alteration in trimethylated-H3K27 levels in HD flies. To further investigate whether the 
methylation state of the H3K27 influences HD pathology, we decided to manipulate this residue directly using post-
translational modification mimicking transgenes. The non-essential endogenous His3.3A gene is located outside of 
the histone gene cluster, transcribed in a replication independent manner and was shown to replace canonical H3 in 
active genes (93, 94). We generated flies carrying transgenes of histone variant His3.3A (UAS-His3.3A) or its point 
mutant forms mimicking His3.3A being methylated (UAS-His3.3A-K27M, lysine mutated to methionine) or 
unmodified (UAS-His3.3-K27R, lysine mutated to arginine) at the K27 position. To test the effects of His3.3A-K27 
PTM mimetics on HTT induced phenotypes while minimizing developmental defects induced by histone mimetics, 
we limited transgene expression to the adult nervous system using a heat sensitive allele of the GAL80 
transcriptional regulator (GAL80
ts
) that inhibits GAL4 driven transcription at 18 °C but relieves it from repression at 
30 °C. To reduce His3.3A gene load, we performed these experiments on flies heterozygous or homozygous for the 
His3.3A
KO
 null mutation. For the tests, we raised flies expressing UAS-Httex1p-Q120 and one of the UAS-His3.3A 
transgenes simultaneously under the combined influence of the elav-GAL4 driver and tub-GAL80
ts 
at 18 °C, and 
transferred them to 30 °C after they eclosed.   
 
Since it is not practical to score for eclosion rate and rhabdomere changes in ommatidia in those flies, we tested 
other aspects of HD pathology induced by HTT expression, e.g. reduced longevity and impaired motor function (95). 
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First, we determined the longevity of male HD flies expressing His3.3A PTM mimic mutations. In general, we 
found the shape of the survival curves of different experimental categories similar with 9-11 days median and 13-15 
days maximum lifespans (Fig. 6A and 6C). The restricted mean lifespan of males heterozygous for His3.3A
KO
 and 
overexpressing Httex1p-Q120 along with either His3.3, His3.3A-K27R or His3.3A-K27M was 9.85, 10.09, and 9.75 
respectively (Fig. 6B). Based on statistical analysis of the data, the lifespan difference of HD flies overexpressing 
His3.3A-K27R and controls overexpressing His3.3A is statistically significant (P=0.04, log-rank test with 
Bonferroni correction), although the effect size is minute. The restricted mean lifespan of males homozygous for 
His3.3A
KO
 and overexpressing Httex1p-Q120 along with either His3.3, His3.3A-K27R or His3.3A-K27M was 10.62, 
10.74, and 9.97 respectively (Fig. 6D). In this case the lifespan difference between HD flies overexpressing 
His3.3A-K27M, and His3.3A or His3.3A-K27R are both statistically significant (P=0.0009 and P=0.0001, 
respectively, log-rank test with Bonferroni correction). Thus, survival data suggest that introduction of His3.3A-K27 
methylation mimetics slightly decrease survival while hindering modification of the K27 residue slightly increases it. 
 
Next, we used a climbing assay to determine the motor abilities of HD flies expressing histone PTM mimetics. To 
characterize climbing ability, we determined the percentage of 10 day old HD flies overexpressing His3.3A, 
His3.3A-K27R, or His3.3A-K27M on a homozygous His3.3A
KO
 background that climbed at least 2.5, 5 or 7.5 cm 
vertically in 10 seconds (Fig. 6E). We found no significant differences in the climbing abilities of flies of different 
genotypes in these tests. Both His3.3A-K27R and His3.3A-K27M overexpressing flies performed slightly better 
than His3.3A control, but these differences were not significant statistically (P=0.29, ANOVA).   
 
Arginine methyltransferases 
Beside lysine methyltransferases, we also tested three protein arginine methyltransferases (PRMT) that fall into the 
Type I and Type II PRMTs protein groups. Members of both groups are capable of both monomethylating and 
dimethylating arginine. However, while Type I enzymes dimethylate the same terminal N atom of the guanidinium 
group of the Arg side chain generating asymmetric dimethylarginine (aDMA); Type II enzymes catalyze the 
addition of a methyl group to each of the terminal N atoms, generating symmetric dimethylarginine (sDMA) (96). 
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Art3 is the ortholog of human PRMT3 whose targets are unknown. We tested two mutant alleles: Art3
MI03542
, in 
which the second exon is disrupted by a Minos element, and Art3
c04615
, a PiggyBac transposon insertion in the first 
intron resulting in the reduction of the mRNA level of the gene below 1% of control (q-RT-PCR data, not shown). 
Heterozygosity of Art3
MI03542
 significantly increased the viability of HD flies (1.47 eclosion rate, P=0.0005, Fig. 7A) 
but did not have a significant effect on neurodegeneration (+0.34 rhabdomeres per ommatidium in Htt Art3
MI03542
/+ 
vs Htt +/+ control, N.S., Fig. 7B).  The Art3c04615 allele did not have a significant effect on either neurodegeneration 
(+0.35, N.S., Fig. 7B) or viability (0.77 eclosion rate, N.S., Fig. 7A). 
 
FBX011 (CG9461), the ortholog of human FBXO11/PRMT9, is a Type II methyltransferase that is also a component 
of an SCF ubiquitin ligase (E3) complex. FBX011 participates in the regulation of apoptosis (97) and miRNA and 
siRNA silencing (98). Heterozygosity of FBX011
MB07449
 allele, in which a Minos element disrupts the first exon of 
the gene, caused increased viability of HD flies (1.72 eclosion rate, P=4.5x10
-6
) while that of FBX011
∆37
 deletion 
allele did not have significant effect on the viability (relative eclosion rate of 1.19, N.S., Fig. 7A). Neither of the 
FBX011 alleles have influenced neurodegeneration (change of rhabdomeres per ommatidia is -0.10 in Htt 
FBX011
∆37
/+ vs control and +0.19 for Htt FBX011
MB07449
 vs control, N.S., Fig. 7B).  
 
DISCUSSION 
Besides Huntington's disease, pathology in a host of other CNS disorders has been correlated with transcriptional 
dysregulation including other polyQ diseases (99, 100), Alzheimer’s (101), Parkinson’s (102), Amyotrophic Lateral 
Sclerosis (ALS) (101) and Rubinstein-Taybi syndrome (103). In this study we address the question whether 
enzymes affecting the status of protein lysine methylation, a posttranslational modification that has a profound effect 
on chromatin structure and gene expression, influence the pathology of HD. By altering the level of enzymes 
responsible for the correct formation of lysine methylation patterns, we found that methyltransferases and 
demethylases affect HD pathology in an intricate manner that suggests target locus specific effects and raises the 
issue of methylation of non-histone proteins.      
 
Our data reveal that manipulation of enzymes that regulate histone marks characteristic of constitutive 
heterochromatin has little or no effect on HD pathology. We found that methyltransferases modifying the H4K20 
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residue, PR-Set7 and Hmt4-20, did not exert a significant effect on HD pathology. Among the five H3K9 specific 
factors tested, only two influenced Htt induced phenotypes: reducing Su(var)3-9 enhanced while reducing JHDM2 
suppressed the negative effect of mutant huntingtin on viability. However, neither of these factors had an impact on 
degeneration of photoreceptor neurons. These results show that manipulation of several categories of methyl 
modifying loci associated with heterochromatin formation does not affect HD pathology and suggest that 
transcriptional dysregulation in HD is not due to major reconfiguration of constitutive heterochromatin. Thus, the 
enzymes acting on constitutive heterochromatic marks can be eliminated as attractive therapeutic candidates.   
 
Analysis of functionally related genes encoding enzymes modifying activating epigenetic methyl marks –including 
methyltransferases and demethylases acting on the H3K4 residue, which is trimethylated on promoters of active 
genes, or on the H3K36 or H3K79 residues that are methylated on the body of transcribed genes – provided 
ambiguous results. We have previously reported reduced H3K4 trimethylation on promoters of down-regulated 
genes in R6/2 mice and human HD samples and showed that partial loss of the H3K4 trimethyl specific demethylase 
Lid ameliorated HD pathology in Drosophila (7). The altered state of H3K4 methylation in post-mortem brain 
samples of HD patients was also observed in a study conducted by Dong and coworkers (104). However that 
analysis found no correlation between H3K4me3 levels at promoters and transcription levels, thus raising the 
possible involvement of non-histone targets of these enzymes or more distal sites of action at distant enhancers of 
prefrontal cortex genes.  
 
In this study we found that reducing other H3K4 specific demethylases beside Lid, i.e. Su(var)3-3 and Kdm2, also 
rescued mutant Htt induced toxicity and neurodegeneration. Unexpectedly, we found that reduction of two out of the 
three tested H3K4 specific methyltransferases, Trx and Trr also suppressed neurodegeneration, although their effect 
on viability was opposite. Experiments aimed at testing enzymes modifying the H3K36 or H3K79 residues gave 
similarly gene specific results: while partial loss of the H3K36 specific methyltransferase Set2 ameliorated 
neurodegeneration, reduction of H3K36 specific Ash1 and the H3K79 specific methyltransferase Gpp enhanced it. 
Furthermore, heterozygous loss of the H3K36 specific demethylase Kdm4A had no effect on degeneration of 
photoreceptor neurons but increased viability.  
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The fact that modulating both the methylating and demethylating activities can have the same effect on HD 
pathology (e.g. H3K4 methylases and demethylases) points to the possibility of a complex set of epigenetically 
regulated disease modifying target loci and/or non-histone protein targets for those methylation modifying enzymes, 
which makes them a challenging therapeutic target. 
 
One of the most important findings of this study is that manipulation of enzymes that affect facultative 
heterochromatin (which is typically dynamically regulated chromatin) impact HD pathology. Specifically, we found 
that loss of function mutations of the catalytic subunit of the PRC2 complex, E(z), that is responsible for H3K27 
trimethylation, enhances neurodegeneration, and similar effects were observed with other components of the PRC2 
complex, Esc and Su(z)12. In contrast, reducing the amount or activity of the H3K27 specific demethylase, Utx, by 
genetic or pharmacological means ameliorated neurodegeneration and reduced HTT aggregation. These findings that 
identify Utx as an appealing target for potential HD therapeutic intervention and are consistent with previous studies 
demonstrating the involvement of misregulated H3K27 methylation in several neurodegenerative disorders. For 
example, the murine PRC2 complex was shown to have a critical role in the maintenance of proper gene expression 
in medium spiny neurons (MSN) that are most affected in HD, by repressing non-neuronal, non-MSN specific and 
cell death promoting genes (105). PRC2 deficiency of Ezh1 and Ezh2 in MSN neurons resulted in progressive fatal 
neurodegeneration, reduction of the number of striatal neurons and impaired motor performance with concurrent 
upregulation of non-MSN-expressed genes and downregulation of MSN-specific genes (105). In contrast, in the 
neurodegenerative disease ataxia-telangiectasia (A-T), reduced activity of PRC2 suppresses pathology. In a murine 
Atm
-/-
 knock-out model of A-T, increased stability and protein level of EZH2 led to a substantial increase in the 
number of H3K27me3 binding sites on chromatin and concurrent reduction of gene expression. This transcriptional 
change had a significant impact on A-T pathology as knock-down of Ezh2 in Atm
-/-
 mice was protective, resulting in 
reduced caspase-3 activation and Purkinje cell degeneration, and increased motor performance (106). PRC2 also 
modulates the severity of Spinal Muscular Atrophy (SMA) by regulating the activity of the Survival Motor Neuron 2 
(SMN2) gene, which is a duplicated gene highly similar to SMN1 that is mutated in SMA (107). In the case of 
Huntington's disease, beside the potential effects of PRC2 activity on neurodegeneration, the role of normal 
huntingtin in the regulation of protein methylation by PRC2 might influence pathology. It was previously reported 
that full-length murine huntingtin physically interacts with Ezh2 and Suz12 and increases the methyltransferase 
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activity of PRC2 in vitro (80). Accordingly, mouse embryos lacking wild-type huntingtin exhibited decreased 
trimethylation of histone H3 at lysine 27 and failed to repress PRC2 regulated Hox gene expression (80).  
 
Despite the phenotypic effects of the opposing H3K27 specific methyltransferase and demethlyase in our model, we 
did not find direct physical evidence that would suggest direct mHtt induced changes in histone H3K27 modification: 
altered H3K27me3 levels could not be detected by either immunoblot or ChIP assays, and direct genetic 
manipulation of the H3K27 residue did not replicate the phenotypic changes observed in E(z) or Utx mutants. This 
raises the possibility that improved pathology in response to manipulation of methyl modifying enzymes may be due 
either to non-histone targets of these proteins or to putative demethylase independent activities.  
 
The activities of several methyltransferases and demethylases are not restricted to histones but they can also modify 
other proteins. For example, EZH2 methylates the transcriptional factors STAT3 and PLZF, which in the case of 
STAT3 leads to increased phosphorylation and enhanced activity (108) while in the case of PLZF, it leads to 
ubiquitylation and degradation of PLZF (109).   
 
Another possibility besides the potential targeting of non-histone proteins is that the effects that Utx mutants exert 
on HTT toxicity may be independent of the demethylase activity of the enzyme. It was demonstrated previously that 
mouse UTY, a Y chromosomal catalytically inactive paralog of UTX, partially complements the effects of loss of 
UTX activity (110). While Utx
-
 females and Utx
-
/Uty
-
 males never pass embryonic stage E18.5 of development, a 
significant portion of hemizygous Utx null males with a wild-type copy of Uty reach adulthood, suggesting that 
demethylase independent activities of UTX/UTY might be crucial during development. These activities might still 
involve transcriptional regulation, as both UTX and UTY were shown to directly bind to and potentiate the activity 
of heart-specific transcriptional factors (110, 111). Furthermore, UTX and UTY both physically interact with 
RBBP5, an H3K4 methyltransferase complex subunit, and the SWI/SNF chromatin remodeler BRG1 (110, 112). 
Drosophila UTX is involved in similar protein interactions as its mammalian counterpart including direct binding to 
the BRG1 homolog nucleosome remodeler BRM (113) and being a subunit of the TRR containing COMPASS-like 
H3K4 methyltransferase complex (33). These conserved interactions suggest that demethylation independent 
activities of Drosophila Utx might be also conserved. Thus, while transcriptional dysregulation is strongly 
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correlated with HD and other neurodegenerative diseases and attention has focused on histone modifications, many 
of the enzymes that regulate these processes have non-histone targets and at least some of them also have additional 
catalytic activities that may contribute to the disease process. Similar to our previous study that pointed to HDAC1 
and SirT1 and SirT2 (114), this study points to the PRC2 component modifying enzyme, Utx, as the most attractive 
therapeutic target among the Drosophila methyl modifying enzymes. 
 
MATERIALS AND METHODS 
Drosophila crosses 
Flies were reared on standard cornmeal molasses medium at 25 °C unless noted otherwise. Genetic interaction 
crosses were done by first mating elav-GAL4; Sp/CyO; +/+ (in case of second chromosomal mutation) or elav-
GAL4; +/+; Sb/TM6 (in case of third chromosomal mutation) females with males carrying the mutation or RNAi 
construct of interest; then crossing the elav-GAL4; mutation/Sp; +/+ or elav-GAL4; +/+; mutation/Sb F1 male 
progeny to w; +/+; UAS-Httex1p-Q93 females. All F2 females express the UAS-Httex1p-Q93 transgene under the 
control of the neuronal elav-GAL4 driver; half of these females carry the mutation of interest in a heterozygous form, 
in F2 males elav-GAL4 is absent therefore they do not express UAS-Httex1p-Q93. To test mutations located on the 
1
st
 chromosome, we set up control crosses with w
1118
 side by side with the experimental crosses in order to compare 
the viability and pseudopupil phenotypes between the mutation-carrying and control flies. Relative eclosion rates 
from ≥1000 segregants were calculated as the ratio of the number of Httex1p-Q93 expressing flies carrying the 
mutation of interest (elav-GAL4/+; Htt/+; mutation/+) and the number of Httex1p-Q93 expressing mutation-free 
control flies (elav-GAL4/+; Htt/+; +/+) divided by the ratio of the number of Htt non-expressing siblings carrying 
the mutation of interest (+/Y; Htt/+; mutation/+) and the number of Htt non-expressing mutation-free siblings (+/Y; 
Htt/+; +/+). P values were based on Fisher’s exact tests.   
 
Pseudopupil analysis 
The insect compound eye is comprised of ~1000 ommatidia (individual eyes) each of which contains 7 visible 
photoreceptor neurons that can be visualized by the specialized light gathering cellular structure called a rhabdomere. 
Pseudopupil analysis allows one to count the number of surviving photoreceptor neurons by counting the light 
gathering rhabdomeres.  Analyses were carried out on 7 day old flies, which were raised 22.5 °C and shifted to 
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25 °C upon eclosion as described in detail (115). Change of rhabdomeres in each ommatidium was calculated as the 
difference of the number of rhabdomeres between the Httex1p-Q93 expressing flies with or without the 
heterozygous mutation of interest and the error bars represent the standard error of the mean (SEM) of difference of 
means. Pseudopupils of  ≥ 5 flies were scored for each genotype. 
 
Drug test 
Crosses of elav-GAL4 (females) x Httex1p-Q93 (males) were carried out in cages at 23 °C. About 60-100 eggs 
collected overnight were transferred to vials of standard cornmeal molasses medium containing indicated 
concentrations of GSK-J4 as described (90) (Tocris Bioscience), 0.1% dimethyl sulfoxide (DMSO, Sigma-Aldrich, 
negative control) or 100 mM butyrate (BA, Sigma-Aldrich, positive control). Freshly eclosed virgin females were 
collected and passed in vials with the corresponding drug/control food every day and aged at 25 °C for 7 days for 
pseudopupil analysis as described (115). 
 
Generation of His3.3A transgenic flies 
Genomic DNA was first prepared from wild-type flies with NucleoSpin Tissue kit (Macherey-Nagel) and the 
genomic region of His3.3A was amplified by PCR using Q5 high-fidelity DNA polymerase (New England Biolabs) 
with primers located upstream (His3.3A_gF) or downstream (His3.3A_gR) of the gene. The 2174 bp amplicon was 
inserted to pJET1.2 vector with CloneJET PCR cloning kit (Thermo Scientific). This clone was used as template in 
PCR to amplify His3.3A from the start codon to the last codon before the stop codon using His3.3A_E3C_F (having 
a KpnI site and an AAA Kozak sequence before the start codon) and His3.3A_E3C_R primers (having an EcoRI 
site). The resulting amplicon was cut with FastDigest KpnI and EcoRI enzymes (Thermo Scientific) and cloned to 
the corresponding sites of pENTRY3C Gateway entry vector. Site directed mutagenesis was performed by 
amplifying the whole pENTRY3C-His3.3A clone in a 22 cycle inverse PCR reaction with Q5 polymerase using a 
common forward primer (K27_F, see Table 1S for all the primer sequences used in the study) and reverse primers 
having base substitutions at the desired positions (K27M_R and K27R_R). After PCR amplicons were 
phosphorylated with T4 polynucleotide kinase (Thermo Scientific), circularized with T4 DNA ligase (Thermo 
Scientific), and treated with DpnI to degrade methylated template DNA. Modified and wild-type H3.3A inserts were 
subcloned to pTWF-attB Gateway destination vector that was modified to carry a φC31 attB sequence at its NsiI 
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restriction site, then these constructs were injected to embryos carrying the attP-zh86Fb φC31 docking site to 
generate transgenic flies by site specific transgene integration. To validate transgenic strains genomic DNA was 
prepared from transgenic flies, transgene sequences were PCR amplified using pTWFattB_Fseq and 
pTWFattB_Rseq primers, and subjected to Sanger sequencing. 
 
Longevity and motor performance of His3.3 mutants 
The effect of His3.3A point mutants on longevity and motor performance in the HD model was tested on elav-GAL4; 
His3.3A
KO
 UAS-Httex1p-Q120/His3.3A
KO
; UAS-His3.3A/tub-GAL80
ts
 flies, in which the UAS-His3.3A transgene 
was either wild-type (UAS-His3.3A-wt), or had a lysine to arginine (UAS-His3.3A-K27R) or lysine to methionine 
(UAS-His3.3A-K27M) substitution. These progeny were generated by mating elav-GAL4; His3.3A
KO
; tub-GAL80
ts
 
females to w; H3.3A
KO
 UAS-Httex1p-Q120; UAS-H3.3A males, raised at 18 °C and transferred to 30 °C after 
eclosion to induce transgene expression in the adult nervous system. To determine longevity, flies were kept at 
30 °C, transferred to fresh vials every second day and the number of deceased individuals recorded daily. At least 
185 flies per genotype was used for longevity analysis.  
 
Climbing assays on elav-GAL4/+; His3.3A
KO
 UAS-Httex1p-Q120/His3.3A
KO
; UAS-His3.3A/tub-GAL80
ts
 flies were 
performed on males that were reared at 18 °C and transferred to 30 °C after eclosion. Groups of 10 days old flies 
were transferred to a glass cylinder and the distance climbed vertically in 10 seconds after knocked to the bottom 
was recorded on video for 8 trials per each group. At least 35 flies divided to several groups were tested for each 
genotype. 
 
Quantitative RT-PCR 
Heads of elav-GAL4>UAS-Httex1p-Q93 with or without mutation (control) female flies were homogenized in 
TRIzol reagent (Invitrogen) and RNA was prepared according to the manufacturers’ recommendations. First strand 
cDNA was prepared from 1 µg of total RNA with Maxima Universal First Strand cDNA Synthesis Kit (Thermo 
Scientific) using random hexamer primers. The resulting cDNA was diluted 1:10 and quantified in qPCR reactions 
with gene specific primers (UAS-F and UAS-R for Htt, G9a-F and G9a-R for G9a, Utx-F and Utx-R for Utx) in an 
MJ Research Opticon thermal cycler using SYBR Green PCR Master Mix (Applied Biosystems). Transgene 
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expression levels were determined compared to a template calibration curve and normalized to that of the rp49 
housekeeping gene. 
 
Immunostaining 
Wandering third instar larvae reared at 25 °C were cut into half in a drop of 1X PBS and flipped inside out. After 
removing extra fat bodies and other tissues, the dissected larvae were incubated in fixative (4% paraformaldehyde 
and 0.2% triton X-100 in 1X PBS) for 20 minutes. The larvae were then washed and blocked with PBSTS (10% 
Bovine serum albumin in PBT) for 1 hour at RT. After that, the larvae were incubated in rabbit polyclonal HTT 
exon1- specific antibody (1:2000 VB3130, Viva Bioscience) overnight at 4 °C. Upon removal of the primary 
antibody, the larvae were blocked again with PBSTS for 1 hour and incubated with secondary antibody solution 
(1:10,000 Alexa 568) for 1.5 hours at RT. Finally, the eye discs were dissected and mounted in Vectashield antifade 
mounting medium (Vector Laboratories). Images were captured with a Zeiss 780 laser scanning confocal 
microscope (Carl Zeiss MicroImaging), using the accompanying Zeiss software. HTT aggregate-positive puncta 
were counted using the “3D Object Counter” plug-in in ImageJ on maximum-intensity compiled 3D images. The 
threshold levels were set to 1800 where most of the aggregates can be clearly identified.  
 
Histone extraction and quantitative western analysis 
For histone extraction, 3 day old female or male fly heads or L2 larvae were homogenized in 5% Triton buffer 
(1X PBS, 5% Triton X-100, 3 mM DTT, 1 mM sodium orthovanadate, 5 mM sodium fluoride, 1 mM PMSF, 5 mM 
sodium butyrate and 1 tablet of Roche’s Complete Mini Protease Inhibitor), spun down at 4,000g for 8 min at 4 °C 
and the pellets containing the nuclei were washed 2x times with the same buffer. The pellets were then resuspended 
in 0.2N HCl and sonicated for 2 times of 10 seconds with 1 min interval at 4 °C. The nuclear histone proteins were 
acid extracted for 3 hours at 4 °C. After centrifugation, the supernatant was neutralized and 2% deoxycholate was 
added to the final concentration of 125~250 µg/ml and the samples were incubated for 10 min at RT. Trichloroacetic 
acid was then added to a final concentration of 6% and the protein pellets were washed with cold acetone. The 
pellets were finally dried and dissolved in appropriate volume of 1X loading buffer (50 mM Tris, pH6.8, 2% SDS, 
10% glycerol, 0.0015% Bromophenol Blue). The samples were boiled for 5 min at 95 °C and loaded to custom-
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made 15% Tris-Tricine polyacrylamide gel and run at a constant voltage of 120 V for about 1 hour until the dye 
reached the bottom of the gel. PVDF membrane was used for standard western blotting. 
 
For quantitative western analysis, blots were blocked for 1 hour at room temperature using 50% 1X PBS diluted 
Odyssey infrared imaging system blocking buffer (LiCor) and then incubated overnight at 4 °C with antibody 
against histone H3K27me3 (Active Motif # 39155, 1:1000). Following incubation with primary antibody, blots were 
washed and incubated with goat anti-rabbit IRDYE 680CW (Li-Cor) secondary antibody (1:20,000) for 1 hour at 
room temperature. Blots were washed and scanned using the Odyssey Infrared Imager (Li-Cor). After scanning, 
blots were incubated with the second primary antibody H2B (Active Motif #61037, 1:2000) overnight at 4 °C, then 
washed and incubated with goat anti-mouse IRDYE 800CW (Li-Cor) secondary antibodies (1:20,000), washed and 
scanned as above. Integrated signal intensity for histone modifications and total H2B was acquired using Odyssey 
Software. Data were exported to Excel and the ratios of signals from different histone modifications to total H2B 
obtained.  
 
Chromatin immunoprecipitation 
Chromatin samples from heads of 3 days old w elav-GAL4/w; Httex1p-Q93/+ and w elav-GAL4/w; Httex1p-Q20/+ 
females were prepared as described previously (116) with modifications. In short, 1500-2500 fly heads were ground 
under liquid N2 and homogenized in homogenization buffer (15 mM HEPES pH 7.6, 10 mM KCl, 5 mM MgCl2, 0.5 
mM EGTA, 0.1 mM EDTA, 0.1% Tween, 350 mM sucrose, with 1 mM DTT, 1 mM PMSF and Protease Inhibitor 
Cocktail (Merck)). Chromatin was crosslinked with 1% formaldehyde for 10 min at RT, then after collection and 
lysis of nuclei fragmented by sonication with a Bioruptor (Diagenode). Samples containing equal amounts of DNA 
as measured by a fluorometric method (Qubit 2.0 with BR DNA assay kit (Life Technologies)) were used for ChIP 
analysis. Diluted samples were pre-cleared with Dynabeads Protein A (Life Technologies) for 4 hours at 4 °C and 
then immunoprecipitated with 3 µg anti-H3 (Abcam ab1791) or anti-H3K27me3 (Millipore 07-449) ChIP-grade 
polyclonal antibody, or no antibody (mock control) at 4 °C overnight. Chromatin-antibody complexes were bound to 
Dynabeads Protein A for 4 hours at 4 °C. The supernatant of the mock control was collected and used as total input 
control (TIC). After extensive washes chromatin was reverse crosslinked overnight at 65 °C, treated with RNase A 
and Proteinase K, extracted with phenol-chloroform then precipitated with ethanol in the presence of glycogen. The 
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amount of immunoprecipitated DNA was determined by quantitative PCR in a PikoReal Real-Time PCR system 
(Thermo Scientific) using Power SYBR Green Mastermix (Life Technologies). Gene specific primers used are listed 
in Supplementary Table 1. The quantity of immunoprecipitated DNA was determined by setting sample Ct values to 
a TIC calibration curve and deducting the amount of DNA in the mock controls.  
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LEGENDS TO FIGURES 
 
Figure 1. Methylases and demethylases acting on active marks H3K4 (A and B), H3K36 (C and D) and H3K79 (E 
and F) had varying effect on HD pathology. The graphs on the left show the effects of heterozygous loss of (A) 
H3K4, (C) H3K36, or (E) H3K79 specific methyltransferases and demethylases on Httex1p-Q93 induced reduced 
viability. Bars show relative eclosion calculated as the following ratio of eclosed progeny: ((Htt-expressing 
methylation mutants) / (Htt-expressing controls)) / ((Htt-non-expressing methylation mutants) / (Htt-non-expressing 
controls)). The graphs on the right show the effects of heterozygous loss of (B) H3K4, (D) H3K36, or (F) H3K79 
specific methyltransferases and demethylases on Httex1p-Q93 induced neurodegeneration. Bars show the 
differences of average number of rhabdomeres per ommatidium in the eyes of methylation mutant Htt expressing 
flies and Htt expressing control siblings. Error bars represent standard error of mean. Significant differences are 
marked by *: P<0.05, **: P<0.01, ***: P<0.001.  
 
Figure 2. Modulating constitutive heterochromatin marks H3K9 and H4K20 methylation has no effect on HD 
pathology. (A) The effects of heterozygous loss of H3K9 specific methyltransferases and demethylases on Httex1p-
Q93 induced reduced viability. Bars show relative eclosion calculated as the following ratio of eclosed progeny: 
((Htt-expressing methylation mutants) / (Htt-expressing controls)) / ((Htt-non-expressing methylation mutants) / 
(Htt-non-expressing controls)). (B) The effects of heterozygous loss of H3K9 specific methyltransferases and 
demethylases on Httex1p-Q93 induced neurodegeneration. Bars show the differences of average number of 
rhabdomeres per ommatidium in the eyes of methylation mutant Htt expressing flies and Htt expressing control 
siblings, error bars represent standard error of mean. (C) The effects of heterozygous loss of H4K20 specific 
methyltransferases on Httex1p-Q93 induced reduced viability. Bars show relative eclosion. (D) The effects of 
heterozygous loss of H4K20 specific methyltransferases on Httex1p-Q93 induced neurodegeneration. Differences of 
average number of rhabdomeres per ommatidium in the eyes of methylation mutant Htt expressing flies and Htt 
expressing control siblings are shown. Error bars represent standard error of mean. Significant differences are 
marked by *: P<0.05, **: P<0.01, ***: P<0.001.  
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Figure 3. Modulating H3K27 methylation has specific effect on HD pathology. (A) The effects of heterozygous loss 
of subunits of the H3K27 specific PRC2 methyltransferase complex and Utx demethylase on Httex1p-Q93 induced 
reduced viability. Bars show relative eclosion calculated as the following ratio of eclosed progeny: ((Htt-expressing 
methylation mutants) / (Htt-expressing controls)) / ((Htt-non-expressing methylation mutants) / (Htt-non-expressing 
controls)). (B) The effects of heterozygous loss of PRC2 subunits and Utx on Httex1p-Q93 induced 
neurodegeneration. Bars show the differences of average number of rhabdomeres per ommatidium in the eyes of 
methylation mutant Htt expressing flies and Htt expressing control siblings. Error bars represent standard error of 
mean.  (C) Utx inhibitor GSK-J4 is neuroprotective as shown by the significantly improved photoreceptor neuron 
survival at concentrations of 10 µM and 100 µM concentrations in flies challenged with Httex1p-Q93. No change in 
neurodegeneration was observed in the 0.1% DMSO vehicle control. 100 mM butyric acid served as positive control. 
Significant differences are marked by *: P<0.05, **: P<0.01, ***: P<0.001. 
 
Figure 4. Reduction of Utx reduces Htt protein accumulation and aggregation but mutant Htt does not affect the 
methylation state of Utx targeted H3K27. (A) Heterozygous reduction of Utx
1
 does not have a significant effect on 
Htt transgene expression as measured by Q-RT-PCR. (B) Htt protein accumulation and aggregation in eye discs of 
elav-GAL4/+; Utx
1
/+; Httex1p-Q120/+ larvae (right) is reduced compared to control elav-GAL4/+; Httex1p-Q120/+ 
larvae (left). Representative compiled 3D confocal Z-stack images of fluorescent eye discs dissected from third 
instar larvae from indicated genotypes are shown. Insets show magnified views of areas outlined with white 
rectangles. Tissues were stained with α-Htt antibody (1:2K VB3130, red) and Hoechst (blue). Images were taken at 
the same settings. (C) Quantification of α-Htt positive puncta in eye discs by 3D Object counting function of ImageJ 
(n>=4) shows that heterozygous reduction of Utx results in reduced Htt aggregation. (D) Representative quantitative 
western blot showing similar signals from Htt challenged (elav-GAL4>Httex1p-Q93) or non-challenged (elav-
GAL4>Httex1p-Q20) heads. Histones prepared from heads of females or males were probed on western blots with 
antibody specific for trimethylated histone H3K27 (Millipore 07-449).  Lanes 13 and 14 show diminished 
H3K27me3 signal from histones prepared from transheterozygotes (Lane 14, E(z)
731
/E(z)
63
) compared to 
heterozygotes (lane 13, E(z)/+). Three biological replicates were analyzed for females and males of each genotype. 
(E) Quantification of H3K27me3 signal intensities normalized to H2B signal from western blots show similar levels 
in elav-GAL4>Httex1p-Q93 and elav-GAL4>Httex1p-Q20 male and female head samples.  
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Figure 5. H3K27me3 occupancy is not altered on candidate genes in mutant Htt expressing flies. The level of 
H3K27me3 modification on genes with H3K27me3 enriched regions was determined by ChIP-qPCR in head 
samples of Httex1p-Q93 or Httex1p-Q20 (control) expressing flies. The tested gene set included genes not expressed 
in neurons (ato, eve, gsb-n, Ubx), and ones with low (eyg, caup, E5, dve, mirr), moderate (Idgf3, hth, mAcR, srp, 
nAcR-beta21C) or high (ninaC, Obp99c) expression levels, and a negative control region (F22) was also included. 
Significant differences were observed in ChIP signal intensity between the tested loci (P=1.04x10
-5
, two-way 
ANOVA) but not in H3K27me3 levels between Httex1p-Q93 and Httex1p-Q20 expressing flies (P=0.961, Two-way 
ANOVA). Bars show the ratio of average ChIP-qPCR signals for H3K27me3 normalized to total input control and 
that for histone H3. Error bars represent standard error of mean (n=3).   
 
Figure 6. Direct manipulation of the H3K27 residue by PTM mimetic exert minor influence on HD pathology. The 
effects of H3K27 modifications on mutant Htt induced reduced longevity and impaired motor activity were 
investigated in flies co-expressing UAS-Httex1p-Q93 and wild-type or point mutant UAS-His3.3A (wtHis3.3A, 
His3.3A-K27R or His3.3A-K27M) in the nervous system in a hetero- or homozygous His3.3A
KO
 background. (A) 
Survival plot shows percent survival of Httex1p-Q93 expressing males heterozygous for His3.3A
KO
 and co-
expressing wtH3.3A (n=185), H3.3A-K27R (n=225) or H3.3A-K27M (n=255) as a function of time. (B) In 
heterozygous His3.3A
KO
 background expression of His3.3A-K27R slightly but significantly increases longevity 
(P=0.0426, log-rank test) of HD flies. Bars show restricted mean lifespan. Error bars represent standard error of 
mean. (C) Percent survival of Httex1p-Q93 expressing males homozygous for His3.3A
KO
 and co-expressing 
wtH3.3A (n=201), H3.3A-K27R (n=234) or H3.3A-K27M (n=216) as a function of time. (D) In homozygous 
His3.3A
KO
 background expression of His3.3A-K27M significantly decreases longevity (P=0.0009, log-rank test) of 
HD flies. Restricted mean lifespan is shown. Error bars represent standard error of mean. (E) Motor activity of flies 
co-expressing UAS-Httex1p and wild-type or point mutant UAS-His3.3A were analyzed by the climbing assay. No 
significant difference between HD flies expressing wtH3.3A, H3.3A-K27R or H3.3A-K27M was found for the 
capability to climb at least 2.5, 5 or 7.5 cm vertically in 10 seconds.     
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Figure 7. The effects of heterozygous reduction of protein arginine methyltransferases (PRMT), Art3 or FBXO11 on 
mutant Htt induced neurodegeneration and reduced viability. (A) Heterozygosity for the Art3
MI03542
 or 
FBX011
MB07449
 alleles significantly increased relative eclosion rate of Httex1p-Q93 expressing flies (P=0.0005 and 
P=4.5x10
-6
, respectively), while other alleles, Art3
c0461
and FBX011
∆37
, did not have a significant effect. (B) None of 
the inspected alleles for Art3 or FBXO11 influenced the degeneration of photoreceptor neurons significantly. Bars 
show the difference of averages of number of rhabdomeres per ommatidium in the eyes of heterozygous PRMT 
mutant Htt expressing flies and Htt expressing control flies. Error bars represent standard error of mean.   
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Table 1. A summary of fly methylases and demethylases tested in the study. The known histone site targets, CG 
numbers and human homologs are listed, and the summary of the observed effects of partial loss of the enzymes on 
mutant Huntingtin induced reduced viability and neurodegeneration are shown. NS: no significant change, E: 
enhancement, Su: suppression, -: not tested, * marks enzymes with activities toward several histone lysine residues. 
Results gained with tests using independent alleles are separated by /. 
 
Site Function 
Fruit fly protein  
/ CG number 
Human homolog 
Effect on reduced 
viability 
Effect on 
neurodegeneration 
Lysine methyltransferases and demethylases 
H3K4 
methylation 
Set1 / CG40351 SETD1A, SETD1B NS NS 
Trx / CG8651 MLL1/2 Su Su 
Trr / CG3848 MLL3/4 E/NS Su/Su 
demethylation 
Su(var)3-3 / CG17149 LSD1 Su Su 
Kdm2 / CG11033* KDM2B Su Su 
Lid / CG9088 JARID1 - - 
H3K9 
methylation 
Egg / CG12196 ESET NS/NS NS/NS 
Su(var)3-9 / CG43664 SUV38H E/Su NS/NS 
G9a / CG2995 G9a NS/E NS/NS 
demethylation 
JHDM2 / CG8165 JHDM2 Su NS 
Kdm4B / CG33182* JMJD2 NS NS 
Kdm4A / CG15835* JMJD2 Su NS 
H3K27 
methylation E(z) / CG6502 Ezh2 E/E E/E 
demethylation Utx / CG5640 UTX/UTY, JMJD3 NS/NS Su/Su 
H3K36 
methylation 
Set2 / CG1716 SET2 NS Su 
Ash1 / CG8887 ASH1 E E 
NSD / CG4976 NSD1 - - 
demethylation 
Kdm4A / CG15835* JMJD2 Su NS 
Kdm2 / CG11033* JHDM1A/1B Su Su 
Kdm4B / CG33182* JMJD2 NS NS 
H3K79 methylation Gpp / Cg42803 DOT1L NS/NS E/E 
H4K20 methylation 
PR-Set7 / CG3307 SET8 NS NS 
Hmt4-20 / CG13363 SUV420H NS NS 
Protein arginine methyltransferases 
unknown methylation Art3 / CG6563 PRMT3 NS/Su NS/NS 
unknown methylation FBXO11 / CG9461 PRMT9/FBXO11 NS/Su NS/NS 
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